Neoantigens in cancer immunotherapy von Schumacher, Ton N., Schreiber, Robert D.

Volltext

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression von Chang, Chih-Hao, Qiu, Jing, O’Sullivan, David, Buck, Michael D., Noguchi, Takuro, Curtis, Jonathan D., Chen, Qiongyu, Gindin, Mariel, Gubin, Matthew M., van der Windt, Gerritje J.W., Tonc, Elena, Schreiber, Robert D., Pearce, Edward J., Pearce, Erika L.

Volltext

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion von Schreiber, Robert D., Old, Lloyd J., Smyth, Mark J.

Volltext

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy von Vesely, Matthew D., Schreiber, Robert D.

Volltext

Tumor neoantigens: building a framework for personalized cancer immunotherapy von Gubin, Matthew M, Artyomov, Maxim N, Mardis, Elaine R, Schreiber, Robert D

Volltext

Natural innate and adaptive immunity to cancer von Vesely, Matthew D, Kershaw, Michael H, Schreiber, Robert D, Smyth, Mark J

Volltext

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy von Molgora, Martina, Esaulova, Ekaterina, Vermi, William, Hou, Jinchao, Chen, Yun, Luo, Jingqin, Brioschi, Simone, Bugatti, Mattia, Omodei, Andrea Salvatore, Ricci, Biancamaria, Fronick, Catrina, Panda, Santosh K., Takeuchi, Yoshiko, Gubin, Matthew M., Faccio, Roberta, Cella, Marina, Gilfillan, Susan, Unanue, Emil R., Artyomov, Maxim N., Schreiber, Robert D., Colonna, Marco

Volltext

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy von Gubin, Matthew M., Esaulova, Ekaterina, Ward, Jeffrey P., Malkova, Olga N., Runci, Daniele, Wong, Pamela, Noguchi, Takuro, Arthur, Cora D., Meng, Wei, Alspach, Elise, Medrano, Ruan F.V., Fronick, Catrina, Fehlings, Michael, Newell, Evan W., Fulton, Robert S., Sheehan, Kathleen C.F., Oh, Stephen T., Schreiber, Robert D., Artyomov, Maxim N.

Volltext

WDFY4 is required for cross-presentation in response to viral and tumor antigens von Theisen, Derek J, Davidson, 4th, Jesse T, Briseño, Carlos G, Gargaro, Marco, Lauron, Elvin J, Wang, Qiuling, Desai, Pritesh, Durai, Vivek, Bagadia, Prachi, Brickner, Joshua R, Beatty, Wandy L, Virgin, Herbert W, Gillanders, William E, Mosammaparast, Nima, Diamond, Michael S, Sibley, L David, Yokoyama, Wayne, Schreiber, Robert D, Murphy, Theresa L, Murphy, Kenneth M

Volltext

Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling von Teijaro, John R., Ng, Cherie, Lee, Andrew M., Sullivan, Brian M., Sheehan, Kathleen C. F., Welch, Megan, Schreiber, Robert D., de la Torre, Juan Carlos, Oldstone, Michael B. A.

Volltext

Type I interferon is selectively required by dendritic cells for immune rejection of tumors von Diamond, Mark S, Kinder, Michelle, Matsushita, Hirokazu, Mashayekhi, Mona, Dunn, Gavin P, Archambault, Jessica M, Lee, Hsiaoju, Arthur, Cora D, White, J Michael, Kalinke, Ulrich, Murphy, Kenneth M, Schreiber, Robert D

Volltext

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape von Noguchi, Takuro, Ward, Jeffrey P, Gubin, Matthew M, Arthur, Cora D, Lee, Sang Hun, Hundal, Jasreet, Selby, Mark J, Graziano, Robert F, Mardis, Elaine R, Korman, Alan J, Schreiber, Robert D

Volltext

Adaptive immunity maintains occult cancer in an equilibrium state von Smyth, Mark J, Schreiber, Robert D, Koebel, Catherine M, Vermi, William, Swann, Jeremy B, Zerafa, Nadeen, Rodig, Scott J, Old, Lloyd J

Volltext

Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8 T Cell Exhaustion and Chronic Viral Infection von Wang, Yaming, Swiecki, Melissa, Cella, Marina, Alber, Gottfried, Schreiber, Robert D., Gilfillan, Susan, Colonna, Marco

Volltext

Cancer immunoediting by the innate immune system in the absence of adaptive immunity von O'Sullivan, Timothy, Saddawi-Konefka, Robert, Vermi, William, Koebel, Catherine M, Arthur, Cora, White, J Michael, Uppaluri, Ravi, Andrews, Daniel M, Ngiow, Shin Foong, Teng, Michele W L, Smyth, Mark J, Schreiber, Robert D, Bui, Jack D

Volltext

The Immunobiology of Cancer Immunosurveillance and Immunoediting von Dunn, Gavin P., Old, Lloyd J., Schreiber, Robert D.

Volltext

The three Es of cancer immunoediting von Dunn, Gavin P, Old, Lloyd J, Schreiber, Robert D

Volltext

Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection von Ng, Cherie T., Sullivan, Brian M., Teijaro, John R., Lee, Andrew M., Welch, Megan, Rice, Stephanie, Sheehan, Kathleen C.F., Schreiber, Robert D., Oldstone, Michael B.A.

Volltext

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo von Swiecki, Melissa, Wang, Yaming, Vermi, William, Gilfillan, Susan, Schreiber, Robert D, Colonna, Marco

Volltext

Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection von Lee, Amanda J, Chen, Branson, Chew, Marianne V, Barra, Nicole G, Shenouda, Mira M, Nham, Tina, van Rooijen, Nico, Jordana, Manel, Mossman, Karen L, Schreiber, Robert D, Mack, Matthias, Ashkar, Ali A

Volltext